ArticleExperimental brain research2026
Spinal cord lesion characteristics and early standing ability with and without epidural stimulation.
Article in Experimental brain research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Current evidence suggests that spinal cord epidural stimulation (scES) can promote aspects of motor recovery for standing, stepping and volitional lower limb movement in research participants with spinal cord injury (SCI), although the extent of such recovery varies among individuals. The goal of this retrospective cohort study was to assess (i) whether the early application of scES, prior to any training with scES, is sufficient to enhance standing ability; and (ii) which magnetic resonance imaging (MRI) biomarkers of spinal cord lesion, if any, are associated with early responsiveness to scES for standing. Twenty-nine non-ambulatory individuals with chronic, severe SCI (n = 27 clinically motor complete; n = 2 motor incomplete) underwent spinal cord MRI and were subsequently implanted with scES. Standing ability was assessed prior to epidural stimulator implant and after implant with scES parameters targeted to facilitate standing (Stand-scES). T2-weighted MRI was used to measure the following spinal cord lesion characteristics: lesion length, midsagittal tissue bridges, and estimates of spared tissue in the anterior, posterior, right, and left spinal cord regions. Early application of continuous Stand-scES significantly improved the ability to stand for longer periods (+ 17%, P = 0.040) and with greater outcomes of independent lower limb extension (P values 0.009-0.042) compared to pre-implant, although responses varied across participants. Notably, shorter spinal cord lesion length and the presence of tissue bridge at the lesion site were positively associated with standing ability promoted by Stand-scES (P values 0.011-0.033). The proposed MRI lesion markers may clarify expectations of early standing recovery with Stand-scES.
Indexed as
Identifiers
42295403What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.